Emerging Injectable Drugs Market Outlook 2016-2024 | Insights, Trends, Demand & Competitors Analysis - PowerPoint PPT Presentation

Loading...

PPT – Emerging Injectable Drugs Market Outlook 2016-2024 | Insights, Trends, Demand & Competitors Analysis PowerPoint presentation | free to download - id: 88992f-MmE1Y



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Emerging Injectable Drugs Market Outlook 2016-2024 | Insights, Trends, Demand & Competitors Analysis

Description:

According to our injectable drugs market report, emerging market trends in biologic medicine is positively impacting injectable drugs market. The global injectable drugs market is segmented on the basis of product type such as vaccines, insulin, conventional therapeutic and biologics. Among these segments, complex biologics segment occupies maximum revenue share of 42.5% in global injectable drugs market and is expected to maintain its dominance over the forecast period. – PowerPoint PPT presentation

Number of Views:7

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Emerging Injectable Drugs Market Outlook 2016-2024 | Insights, Trends, Demand & Competitors Analysis


1
Report Code HC1005
Emerging Injectable Drugs Market Outlook
2016-2024 Insights, Trends, Demand
Competitors Analysis
1-646-568-7747
1-437-886-1181
44-203-318-6627
91-120-473-0422, 91-844-785-9968
sales_at_goldsteinresearch.com
2
Emerging Injectable Drugs Market Outlook
2016-2024 Insights, Trends, Demand
Competitors Analysis
Global Injectable Drugs Market Outlook Drugs
which are introduced into body with syringe
needle as a medium is termed as injectable drugs.
Among all the approved drugs by Food Drug
Administration (FDA) available in U.S., 97 of
medications vaccines are administered through
injections. Top injectable drugs such as
remicade, avastin neulasta, rituxan, etc. are
most commonly used across the globe. In 2012,
over 180,000 units of remicade were available per
one million lives worldwide. Nowadays, increasing
price of injectable biotech products is a
challenge for every commercial player in the
United Sates. In 2010, approval of several cancer
therapies by FDA has driven the cost of
injectable drugs up to 4.0. However, injectable
drugs used for cancer treatment accounted for
more than 50.0 of benefits of medical injectable
costs. Recent increase in commercial health plans
is establishing attractive business opportunities
for injectable drugs in Europe and North America
region. In 2012, more than 60 of population in
the United States received medical benefits,
which is extensively raising the demand of
injectable drugs in the region. Although, illegal
use of injectable drugs is expected to hamper the
adoption rate of injectable drugs across the
globe. In 2012, Greece and the UK have 3.1 and
nearly 10 of per 1000 population who were using
injectable drugs illegally. Spain, UK, France and
Italy has higher rate of abusing medical drugs as
compared to other European countries. Moreover,
the U.S. and Canada have nearly 3.0 of
population aged above 12 years are illegally
using medical injectable drugs. This is one of
the major factors which are obstructing the
injectable drugs market. However, stringent drugs
polices is likely to reduce the illegitimate use
of injectable drugs worldwide. Acquisition and
collaboration plays an important role in enabling
business opportunities for injectable drugs. For
instance, In July 2016, Lupin pharmaceutical
acquired two medical companies of New Jersey
worth USD 900 million. In the same year, InvaGen
Pharmaceutical was acquired by Cipla for USD 550
million. In October 2016, India based company
Piramal announced to buy 5 drugs for pain and
anesthetic management from Johnson Johnson by
paying USD 155 million. Piramal holds a
significant presence in global generic injectable
drug market which valued USD 20 billion in 2016.
These acquisitions and partnerships are expected
to drive the growth of injectable drugs market
during the time period of 2016-2024.
3
Emerging Injectable Drugs Market Outlook
2016-2024 Insights, Trends, Demand
Competitors Analysis
  • Market Segmentation
  • Based on Product Type
  • Vaccines
  • Insulin
  • Conventional Therapeutics
  • Complex Biologics
  • Send Us Sample Request_at_ https//www.goldsteinresea
    rch.com/request-sample/global-injectable-drugs-mar
    ket-outlook-2024-global-opportunity-and-demand-ana
    lysis-market-forecast-2016-2024

Sample Request
4
Emerging Injectable Drugs Market Outlook
2016-2024 Insights, Trends, Demand
Competitors Analysis
  • Based on Geography
  • North America (US, Canada) Market Share (),
    Market Size (USD Million), Production (Units)
  • Europe (UK, France, Italy, Germany, Spain,
    Hungary, Sweden, Russia, Poland and Rest of
    Europe) Market Share (), Market Size (USD
    Million), Production (Units)
  • Middle East and Africa (GCC Countries, North
    Africa, South Africa and Rest of Middle East
    Africa) Market Share (), Market Size (USD
    Million), Production (Units)
  • Latin America (Brazil, Mexico and Rest of Latin
    America) Market Share (), Market Size (USD
    Million) , Production (Units)
  • Asia Pacific (China, Japan, India, Singapore,
    South Korea, Australia, New Zealand and Rest of
    Asia-Pacific) Market Share (), Market Size (USD
    Million), Production (Units)
  • Rest of the World Market Share (), Market Size
    (USD Million), Production (Units)

5
Emerging Injectable Drugs Market Outlook
2016-2024 Insights, Trends, Demand
Competitors Analysis
Market Size and Forecast (2016-2024) Global
injectable drugs market is anticipated to reach
USD 513.5 billion by 2024 from value USD 272.7
billion in 2016, growing at a CAGR of 8.23
during the forecast period of 2016 to 2024. North
America is the dominating region in global
injectable drugs market in 2016. Rising number of
chronic health issues and increasing number of
partnership between medical companies to provide
high quality affordable drugs is boosting the
demand of injectable drugs in U.S. and Canada.
North America valued 109.1 billion in 2016 and is
expected to reach USD 184.9 billion by
2024. Based on segmentation, complex biologics
holds the largest share nearly 60.0 of global
injectable drugs market in 2016. Increase in
number of new drugs rising demand for license
approval for biologics and new drugs is
accelerating the market of complex biologics
segment. Vaccines and insulin segment is expected
to witness notable growth with 20.0 and 10.0
share of injectable drugs market over the
forecast period. Asia-Pacific region is expected
to be the fastest growing region in injectable
drug market over the forecast period.
Asia-Pacific region is expected to reach the
value of USD 133.5 billion by the end of 2024,
growing at a CAGR of 10.51 over the forecast
period. Rising health awareness and growing
penetration of self injection technology in
Japan, Singapore China is boosting the demand
of injectable drugs in the region. Increasing
number of diabetes population in emerging
economies such as India China is expected to
witness significant growth during the time period
of 2016-2024.  
6
Emerging Injectable Drugs Market Outlook
2016-2024 Insights, Trends, Demand
Competitors Analysis
Global Injectable Drugs Market Outlook 2024
contains detailed overview of the global
injectable drugs market in terms of market
segmentation by product type. Further, for the
in-depth analysis, the report encompasses the
industry growth drivers, market challenges, risk
analysis, market attractiveness, BPS (Base Point
Sacle) analysis, Porters five force model and
SWOT analysis. Global Injectable Drugs Market
Report also provides competitive outlook of some
of the major players of the global injectable
drugs market which includes profiling of
companies Pfizer Inc., Johnson Johnson,
Novartis AG, Merck Co. Inc., . The company
profiles include business strategy, geographical
revenue distribution, major information of the
companies which encompasses business outlook,
products, services and industries catered,
financial analysis of the company and recent
developments. Overall, the report represents
comprehensive synopsis on the global injectable
drugs market that will help industry consultants,
equipment manufacturers, existing players
searching for expansion opportunities, new
players searching possibilities and other
stakeholders to align their market centric
strategies according to the ongoing and expected
trends in the future. Request for TOC_at_
https//www.goldsteinresearch.com/toc-request/glob
al-injectable-drugs-market-outlook-2024-global-opp
ortunity-and-demand-analysis-market-forecast-2016-
2024
7
Emerging Injectable Drugs Market Outlook
2016-2024 Insights, Trends, Demand
Competitors Analysis
  • Scope Background
  •  Market Synopsis
  •  
  • Market Segmentation
  •  
  • The Injectable Drugs market Segmentation as
    follows
  • By Product Types (Market Size, Demand Analysis
    and Growth Analysis)
  • By Country
  • North America (U.S., Canada) Market Size, Growth
    Analysis and Opportunity Analysis
  • Latin America (Argentina, Mexico, Brazil and Rest
    of Latin America) Market Size, Growth Analysis
    and Opportunity Analysis
  • Europe (Germany, Italy, Spain, France, The U.K.,
    Netherlands, Sweden, Hungary, Russia, Poland,
    Rest of Europe) Market Size, Growth Analysis and
    Opportunity Analysis
  • Asia-Pacific (China, India, Singapore, Japan,
    Australia, New Zealand, South Korea and Rest of
    Asia Pacific) Market Size, Growth Analysis and
    Opportunity Analysis
  • Middle East and North Africa (MENA) Market Size,
    Growth Analysis and Opportunity Analysis
  • Rest of World  Market Size, Growth Analysis and
    Opportunity Analysis

Sample Request
8
Emerging Injectable Drugs Market Outlook
2016-2024 Insights, Trends, Demand
Competitors Analysis
  • Market Dynamics Growth Drivers, Restraints and
    Opportunities
  • Risk Factors
  • Regional Variations
  • Recent Trends and Developments
  • Key Market Players
  • Synopsis
  • Business Strategy
  • Product Portfolio
  • SWOT Analysis
  • Porters Five Force Model
  • Market Landscape Competition and Beyond
  • Market outlook for business players and entry
    level players to ascertain their business in
    dynamic ecosystem
  • Expert Analysis
  • Concluding Remarks

Sample Request
9
Emerging Injectable Drugs Market Outlook
2016-2024 Insights, Trends, Demand
Competitors Analysis
About Goldstein Research Based in U.S., Goldstein
Research is a young business consulting and
market research firm with vast reach across
America, Asia and parts of Europe and the Middle
East. In the next five years, we strive to
expand our reach to 50 nations spanning across
Europe, Asia and parts of the Middle East and
Africa. We strive to realize a strong brand
presence globally through our quality research
and forecasting solutions. With 30 domain
experts and 50 employees working day and night
to crunch numbers and bring out the best and
detailed market reports and forecasts, we strive
to enable you to foresee upcoming market
challenges and develop a robust business model
and strategies, which would add to your
profitability and market visibility as a
brand. Our mission is simple to develop
insightful business solutions, help our clients
make powerful future decisions to keep them well
ahead of the game which is the market, and leave
a mark across businesses and communities through
our well-defined ideas and clear cut forecasts.
Our mission is simple to develop insightful
business solutions, help our clients make
powerful future decisions to keep them well ahead
of the game which is the market, and leave a mark
across businesses and communities through our
well-defined ideas and clear cut forecasts.
10
Emerging Injectable Drugs Market Outlook
2016-2024 Insights, Trends, Demand
Competitors Analysis
Sample Request
For more information Contact Us
11
Emerging Injectable Drugs Market Outlook
2016-2024 Insights, Trends, Demand
Competitors Analysis
Thank you
Thank you
About PowerShow.com